HonCode

Go Back   HER2 Support Group Forums > Search Forums
Register Gallery FAQ Members List Calendar Today's Posts

Showing results 1 to 6 of 6
Search took 0.01 seconds.
Search: Posts Made By: gdpawel
Forum: Articles of Interest 02-28-2011, 05:21 PM
Replies: 8
Views: 4,817
Posted By gdpawel
Re: Impact of a chemoresponse assay on treatment costs for recurrent ovarian cancer

Rich

Rational Therapeutics does test the aromatase inhibitors. Their mode of action is to decrease the synthesis of estradiol in the body tissues and as such do not give a measureable signal in...
Forum: Articles of Interest 09-24-2010, 03:36 PM
Replies: 8
Views: 4,817
Posted By gdpawel
More evidence

There has been more evidence that wide-scale adoption of chemoresponse assays would help not just patients, but consumers and insurance companies as well.

In June 2009, DiaTech Oncology presented...
Forum: Articles of Interest 09-05-2010, 02:46 PM
Replies: 8
Views: 4,817
Posted By gdpawel
What is the precedent for using cell culture assay tests?

There isn't one paper, or two, which by itself, makes a case for or against cell-based assays. Nor does the proposition that the whole thing depends on one study or even one review. You've got to...
Forum: Articles of Interest 05-01-2010, 06:04 PM
Replies: 8
Views: 4,817
Posted By gdpawel
Re: Impact of a chemoresponse assay on treatment costs for recurrent ovarian cancer

The National Comprehensive Cancer Network (NCCN) updated the NCCN Clinical Practice Guidelines for Oncology to include the use of chemoresponse assays.

The NCCN states that chemoresponse assays...
Forum: Articles of Interest 04-29-2010, 04:48 PM
Replies: 8
Views: 4,817
Posted By gdpawel
New Paradigms of Doing Business

It amazes me not only that some private insurance carriers don't like to pay for oncologic in vitro chemoresponse assays but that they don't emphatically mandate it as a requirement for obtaining...
Forum: Articles of Interest 04-29-2010, 04:47 PM
Replies: 8
Views: 4,817
Posted By gdpawel
Impact of a chemoresponse assay on treatment costs for recurrent ovarian cancer

Impact of a chemoresponse assay on treatment costs for recurrent ovarian cancer.

Havrilesky LJ, Krivak TC, Mucenski JW, Myers ER.
Division of Gynecologic Oncology, Department of Obstetrics and...
Showing results 1 to 6 of 6

 
Forum Jump

All times are GMT -7. The time now is 10:06 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter